Spotlight: Implications of Just Published New PTAB Rules
The use of inter partes review (IPR) to challenge bio/pharma patents has grown significantly — with the number nearly doubling in 2015 alone. While relatively few of them have reached final decisions, what gives some challengers the winning edge?
Please join our experienced attorneys for a discussion on the key challenges you could face with your next IPR, as well as your overall strategies for patent litigation and enforcement, and how to prepare to address them.
Topics include:
- Determining trends based on the first 105+ bio/pharma IPR petitions to be filed
- Discovering the most vulnerable types of bio/pharma patents
- Learning how to prosecute bio/pharma patents to withstand IPR
- Employing tactics to help prevent an institution decision
- Understanding more about biosimilar and biologics-related IPRs
- Reviewing updates on PTAB rule changes
Speakers
Stephen Maebius, Partner, IP Department, Foley & Lardner LLP
Kristel Schorr, Partner and Chair, Chemical, Biotechnology & Pharmaceutical Practice, Foley & Lardner LLP
Moderator
Etsuo Doi, Managing Partner, Tokyo Office, Foley & Lardner LLP
People
Related Insights
01 May 2024
Article
DOJ and FTC Raise Concerns about Overlapping Ownership in Public Utility Companies
On April 25, 2024, the U.S. Department of Justice Antitrust Division and the Federal Trade Commission filed a joint comment with the Federal Energy Regulatory Commission raising concerns about FERC’s blanket authorization policy, which, among other things, allows holding companies, including investment companies, to acquire noncontrolling ownership interests in public utility companies, subject to certain conditions.
22 May 2024
Events
May 2024 Midwest Cyber Security Alliance Meeting | Integrating Trending AI and CMMC Compliance Into Vendor Management
Join us on Wednesday, May 22, 2024, at the next Midwest Cyber Security Alliance meeting, where sponsor Sikich LLP, along with Foley attorneys Chanley Howell and Leighton Allen, will delve into the integration of two critical components — AI due diligence and Cybersecurity Maturity Model Certification (CMMC) compliance — to fortify vendor management practices.
16 May 2024
Events
Litigating Patent Claims at the ITC and How It Could Impact Your Company
The U.S. International Trade Commission is a fast-paced, high-stakes forum empowered by Section 337 of the U.S. Tariff Act to hear and resolve patent infringement complaints brought by companies against acts in the importation of products.